{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T07:21:00Z","timestamp":1794900060979,"version":"4.9.1"},"reference-count":32,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,12,1]]},"abstract":"<jats:p>Plasmacytoid urothelial carcinoma (PUC) is a variant of infiltrating urothelial carcinoma that is characterized by tumor cells that have striking morphologic resemblance to and immunohistochemical overlap with plasma cells, and that harbors CDH1 mutation. Plasmacytoid urothelial carcinoma can be widely infiltrative and may permeate the urinary bladder in a linitis plastica\u2013like manner and spread along the fascial planes and into the peritoneum. Compared with conventional urothelial carcinoma, PUCs have a greater chance for higher-stage disease, surgical margin positivity, and metastasis at presentation that translate into its poorer outcome. Upstaging of lamina propria\u2013invasive (pT1) tumors diagnosed at transurethral resections is common. Because of its unfavorable behavior, a more aggressive management approach is being recommended for PUC, including consideration for upfront cystectomy in pT1 tumors. Thus, accurate distinction should be made especially on the initial transurethral resection specimens because of the therapeutic and prognostic implications. Awareness of PUC's unique clinical presentation, morphology, and immunohistochemical profile is important to avoid a potential misdiagnosis from its mimics.<\/jats:p>","DOI":"10.5858\/arpa.2018-0139-rs","type":"journal-article","created":{"date-parts":[[2019,3,13]],"date-time":"2019-03-13T15:41:11Z","timestamp":1552491671000},"page":"1562-1567","source":"Crossref","is-referenced-by-count":29,"title":["Plasmacytoid Urothelial Carcinoma: An Unusual Variant That Warrants Aggressive Management and Critical Distinction on Transurethral Resections"],"prefix":"10.5858","volume":"143","author":[{"given":"Sadhika","family":"Sood","sequence":"first","affiliation":[{"name":"From Kasturba Medical College, Manipal Academy of Higher Education (MAHE), Mangalore, Karnataka, India (Ms Sood); and the Departments of Pathology and Surgery (Urology), University of Chicago Medical Center, Chicago, Illinois (Dr Paner). At the time of acceptance, Ms Sood was currently a rotating medical student in the Department of Pathology, University of Chicago Medical Center."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gladell P.","family":"Paner","sequence":"additional","affiliation":[{"name":"From Kasturba Medical College, Manipal Academy of Higher Education (MAHE), Mangalore, Karnataka, India (Ms Sood); and the Departments of Pathology and Surgery (Urology), University of Chicago Medical Center, Chicago, Illinois (Dr Paner). At the time of acceptance, Ms Sood was currently a rotating medical student in the Department of Pathology, University of Chicago Medical Center."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3906","published-online":{"date-parts":[[2019,3,13]]},"reference":[{"issue":"1","key":"2020081203364069500_i1543-2165-143-12-1562-b01","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21442","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"suppl 2","key":"2020081203364069500_i1543-2165-143-12-1562-b02","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1038\/modpathol.2009.26","article-title":"Histological variants of urothelial carcinoma: diagnostic, therapeutic and prognostic implications","volume":"22","author":"Amin","year":"2009","journal-title":"Mod Pathol"},{"issue":"5","key":"2020081203364069500_i1543-2165-143-12-1562-b03","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/MOU.0b013e328363e415","article-title":"Should histologic variants alter definitive treatment of bladder cancer?","volume":"23","author":"Willis","year":"2013","journal-title":"Curr Opin Urol"},{"issue":"5","key":"2020081203364069500_i1543-2165-143-12-1562-b04","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/MOU.0000000000000089","article-title":"Variant histology: role in management and prognosis of nonmuscle invasive bladder cancer","volume":"24","author":"Porten","year":"2014","journal-title":"Curr Opin Urol"},{"key":"2020081203364069500_i1543-2165-143-12-1562-b05","first-page":"81","article-title":"Infiltrating urothelial carcinoma","author":"Gignon","year":"2016","journal-title":"WHO Classification of Tumours of the Urinary System and Male Genital Organs. 4th ed"},{"issue":"4","key":"2020081203364069500_i1543-2165-143-12-1562-b06","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.juro.2016.06.049","article-title":"Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO guideline","volume":"196","author":"Chang","year":"2016","journal-title":"J Urol"},{"key":"2020081203364069500_i1543-2165-143-12-1562-b07","article-title":"NCCN Clinical Practice Guidelines in Oncology","year":"2018","journal-title":"Bladder Cancer"},{"key":"2020081203364069500_i1543-2165-143-12-1562-b08","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2017.06.013","article-title":"The impact of plasmacytoid variant histology on the survival of patients with urothelial carcinoma of bladder after radical cystectomy","author":"Li","year":"2017]","journal-title":"Eur Urol Focus"},{"key":"2020081203364069500_i1543-2165-143-12-1562-b09","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.urology.2016.09.053","article-title":"Outcomes following radical cystectomy for plasmacytoid urothelial carcinoma: defining the need for improved local cancer control","volume":"102","author":"Cockerill","year":"2017","journal-title":"Urology"},{"issue":"5","key":"2020081203364069500_i1543-2165-143-12-1562-b10","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1093\/ajcp\/aqx029","article-title":"Plasmacytoid urothelial carcinoma of the urinary bladder: a clinicopathologic and immunohistochemical analysis of 49 cases","volume":"147","author":"Fox","year":"2017","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"2020081203364069500_i1543-2165-143-12-1562-b11","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/j.juro.2012.11.084","article-title":"Plasmacytoid urothelial carcinoma, a chemosensitive cancer with poor prognosis, and peritoneal carcinomatosis","volume":"189","author":"Dayyani","year":"2013","journal-title":"J Urol"},{"issue":"5","key":"2020081203364069500_i1543-2165-143-12-1562-b12","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.urology.2013.12.035","article-title":"Plasmacytoid bladder cancer: variant histology with aggressive behavior and a new mode of invasion along fascial planes","volume":"83","author":"Kaimakliotis","year":"2014","journal-title":"Urology"},{"issue":"6","key":"2020081203364069500_i1543-2165-143-12-1562-b13","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.urolonc.2014.03.008","article-title":"Plasmacytoid variant urothelial bladder cancer: is it time to update the treatment paradigm?","volume":"32","author":"Kaimakliotis","year":"2014","journal-title":"Urol Oncol"},{"key":"2020081203364069500_i1543-2165-143-12-1562-b14","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1471-2407-13-71","article-title":"Plasmacytoid variant of bladder cancer defines patients with poor prognosis if treated with cystectomy and adjuvant cisplatin-based chemotherapy","volume":"13","author":"Keck","year":"2013","journal-title":"BMC Cancer"},{"issue":"3","key":"2020081203364069500_i1543-2165-143-12-1562-b15","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.juro.2011.10.145","article-title":"Plasmacytoid carcinoma of the bladder: a urothelial carcinoma variant with a predilection for intraperitoneal spread","volume":"187","author":"Ricardo-Gonzalez","year":"2012","journal-title":"J Urol"},{"issue":"7","key":"2020081203364069500_i1543-2165-143-12-1562-b16","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.humpath.2009.01.001","article-title":"Plasmacytoid urothelial carcinoma of the bladder","volume":"40","author":"Lopez-Beltran","year":"2009","journal-title":"Hum Pathol"},{"issue":"3","key":"2020081203364069500_i1543-2165-143-12-1562-b17","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/PAS.0b013e318186c45e","article-title":"Plasmacytoid urothelial carcinoma: detailed analysis of morphology with clinicopathologic correlation in 17 cases","volume":"33","author":"Nigwekar","year":"2009","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"2020081203364069500_i1543-2165-143-12-1562-b18","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1016\/j.juro.2008.07.035","article-title":"Plasmacytoid urothelial carcinoma of the bladder: histological and clinical features of 5 cases","volume":"180","author":"Fritsche","year":"2008","journal-title":"J Urol"},{"issue":"5","key":"2020081203364069500_i1543-2165-143-12-1562-b19","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1097\/PAS.0b013e318159af9e","article-title":"Plasmacytoid transitional cell carcinoma of urinary bladder: a clinicopathologic study of 9 cases","volume":"32","author":"Ro","year":"2008","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"2020081203364069500_i1543-2165-143-12-1562-b20","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.eururo.2005.12.047","article-title":"Plasmacytoid urothelial carcinoma of the urinary bladder report of seven new cases","volume":"50","author":"Mai","year":"2006","journal-title":"Eur Urol"},{"issue":"3","key":"2020081203364069500_i1543-2165-143-12-1562-b21","first-page":"277","article-title":"Plasmacytoid transitional cell carcinoma: report of a case with initial presentation mimicking multiple myeloma","volume":"35","author":"Sahin","year":"1991","journal-title":"Acta Cytol"},{"issue":"6","key":"2020081203364069500_i1543-2165-143-12-1562-b22","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/00000478-199106000-00005","article-title":"Carcinomas of the urinary bladder simulating malignant lymphoma: a report of five cases","volume":"15","author":"Zukerberg","year":"1991","journal-title":"Am J Surg Pathol"},{"issue":"1\u20132","key":"2020081203364069500_i1543-2165-143-12-1562-b23","doi-asserted-by":"crossref","first-page":"E50","DOI":"10.5489\/cuaj.3789","article-title":"Plasmacytoid urothelial carcinoma (PUC): Imaging features with histopathological correlation","volume":"11","author":"Chung","year":"2017","journal-title":"Can Urol Assoc J"},{"issue":"7","key":"2020081203364069500_i1543-2165-143-12-1562-b24","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.humpath.2014.02.024","article-title":"Immunohistochemical evaluation of novel and traditional markers associated with urothelial differentiation in a spectrum of variants of urothelial carcinoma of the urinary bladder","volume":"45","author":"Paner","year":"2014","journal-title":"Hum Pathol"},{"issue":"11","key":"2020081203364069500_i1543-2165-143-12-1562-b25","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1097\/PAS.0000000000000922","article-title":"Immunohistochemical differentiation of plasmacytoid urothelial carcinoma from secondary carcinoma involvement of the bladder","volume":"41","author":"Borhan","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"2020081203364069500_i1543-2165-143-12-1562-b26","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.humpath.2010.11.011","article-title":"Plasmacytoid urothelial carcinoma of the urinary bladder: clinicopathologic, immunohistochemical, ultrastructural, and molecular analysis of a case series","volume":"42","author":"Raspollini","year":"2011","journal-title":"Hum Pathol"},{"issue":"2","key":"2020081203364069500_i1543-2165-143-12-1562-b27","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1159\/000326742","article-title":"Plasmacytoid urothelial carcinoma of the bladder: a case report and the first description of urinary cytology","volume":"46","author":"Zhang","year":"2002","journal-title":"Acta Cytol"},{"issue":"4","key":"2020081203364069500_i1543-2165-143-12-1562-b28","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1365-2303.2009.00660.x","article-title":"Urine cytological findings of plasmacytoid urothelial carcinoma of urinary bladder: report of two cases","volume":"20","author":"Sakuma","year":"2009","journal-title":"Cytopathology"},{"issue":"4","key":"2020081203364069500_i1543-2165-143-12-1562-b29","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/dc.22867","article-title":"Plasmacytoid urothelial carcinoma\u2013diagnostic challenge in cytology","volume":"41","author":"Molek","year":"2013","journal-title":"Diagn Cytopathol"},{"issue":"7","key":"2020081203364069500_i1543-2165-143-12-1562-b30","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1245\/s10434-012-2709-4","article-title":"Nuclear E-cadherin expression is associated with the loss of membranous E-cadherin, plasmacytoid differentiation and reduced overall survival in urothelial carcinoma of the bladder","volume":"20","author":"Keck","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"2020081203364069500_i1543-2165-143-12-1562-b31","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/ijc.25700","article-title":"The plasmacytoid carcinoma of the bladder\u2013rare variant of aggressive urothelial carcinoma","volume":"129","author":"Keck","year":"2011","journal-title":"Int J Cancer"},{"issue":"4","key":"2020081203364069500_i1543-2165-143-12-1562-b32","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/ng.3503","article-title":"Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancer","volume":"48","author":"Al-Ahmadie","year":"2016","journal-title":"Nat Genet"}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/143\/12\/1562\/2468650\/arpa_2018-0139-rs.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/143\/12\/1562\/2468650\/arpa_2018-0139-rs.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:36:45Z","timestamp":1764790605000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/143\/12\/article-p1562.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,13]]},"references-count":32,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2019,3,13]]},"published-print":{"date-parts":[[2019,12,1]]}},"URL":"https:\/\/doi.org\/10.5858\/arpa.2018-0139-rs","relation":{},"ISSN":["0003-9985","1543-2165"],"issn-type":[{"value":"0003-9985","type":"print"},{"value":"1543-2165","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,13]]}}}